Advancing technology and a unique wealth of knowledge are the driving forces behind innovative development in our PathFlow® portfolio of diagnostic tests for infectious diseases. Our latest addition to the range - the PathFlow® SARS-CoV-2 IgG - is an easy-to-use, rapid, lateral flow test for the detection of COVID-19 antibodies. It's a natural evolution in [...]The post Novacyt Group: PathFlow® technology and knowledge underpin our drive for continued innovation appeared first on Primerdesign Real-Time PCR Blog.